Department of General Surgery and Medical Surgery Specialties, Gynecological Clinic, University of Catania, Italy.
Humanitas Medical Care Catania, Catania, Italy.
Infect Dis Obstet Gynecol. 2021 Mar 9;2021:6627531. doi: 10.1155/2021/6627531. eCollection 2021.
The natural history of the CIN1 lesions is characterized by an elevated rate of spontaneous regression (80%), some authors recognize a capacity to progress to HSIL in 10% of cases, and other authors do not recognize the capacity of progression of LSIL (CIN1). This study was aimed to evaluate the incidence of progression to HSIL (CIN3) in women with a histological diagnosis of LSIL (CIN1). Furthermore, to this end, we studied the histological outcomes of cone specimens collected by the LEEP.
All the data were retrospectively analyzed. All participants underwent a follow-up of 4 years, during which each woman underwent an HPV test and genotyping, cervical cytological sampling, or biopsy every six months. The endpoint was the histological confirmation of CIN3 lesions in any moment during follow-up.
Progression to CIN3 occurred in 7 cases (1,5%). Analyzing the histological exams of the cones of the 7 cases that progressed to CIN3, we found the coexistence of CIN1 and CIN3 lesions in all cases.
After 4 years of follow-up, only 1.5% (7/475) of the women with LSIL developed CIN3, all within the first two years of follow-up, and were immediately treated. The most likely explanations for "progression" from LSIL to HSIL are (1) actual progression, (2) underdiagnosis of HSIL on initial biopsy, (3) overdiagnosis of HSIL on follow-up biopsy/cone, and (4) CIN3 arose de novo. Analyzing the histological exams of the cones of the 7 cases that progressed to high-grade, we found the coexistence of CIN1 and CIN3 lesions in all cases. Some recent studies have shown that a viral genotype corresponds to different lesions in the same cervix; therefore, CIN1 coexisting with CIN3 does not always indicate progression of CIN1. Other authors have doubted the capacity of LSIL to progress.
CIN1 病变的自然史以自发消退率高为特征(80%),一些作者认为在 10%的病例中有进展为 HSIL 的能力,而其他作者则不承认 LSIL(CIN1)进展的能力。本研究旨在评估组织学诊断为 LSIL(CIN1)的女性进展为 HSIL(CIN3)的发生率。此外,为此,我们研究了 LEEP 采集的锥形标本的组织学结果。
所有数据均进行回顾性分析。所有参与者均随访 4 年,在此期间,每位女性每 6 个月接受一次 HPV 检测和基因分型、宫颈细胞学采样或活检。终点是在随访期间的任何时候组织学证实 CIN3 病变。
7 例(1.5%)进展为 CIN3。分析 7 例进展为 CIN3 的锥形组织学检查,我们发现所有病例均存在 CIN1 和 CIN3 病变共存。
随访 4 年后,仅 1.5%(475 例中的 7 例)LSIL 女性发展为 CIN3,均在前两年的随访中发现,并立即治疗。从 LSIL 到 HSIL 的“进展”最可能的解释是:(1)实际进展,(2)初始活检中 HSIL 的漏诊,(3)随访活检/锥形中的 HSIL 的过度诊断,以及(4)CIN3 是新出现的。分析进展为高级别病变的 7 例锥形组织学检查,我们发现所有病例均存在 CIN1 和 CIN3 病变共存。一些最近的研究表明,病毒基因型对应于同一宫颈中的不同病变;因此,CIN1 与 CIN3 共存并不总是表明 CIN1 的进展。其他作者对 LSIL 进展的能力表示怀疑。